Clinical trial Recruiting at 1 site Interventional Ages 40 to 80

Enhancing Deep Sleep in Depression with Non-Invasive Brain Stimulation

Official title: Investigating Slow Wave Sleep Enhancement to Improve Cognitive Function in Adults With Depression

Run by Wake Forest University Health Sciences · NCT07143838 · Data updated 2026-11-12

This pilot test will try non-invasive brain stimulation during sleep to see if it increases deep sleep and improves mood and thinking in adults with major depressive disorder.

Quick facts

Study typeInterventional
Ages40 Years to 80 Years
SexAll
Enrollment12 (estimated)
SponsorWake Forest University Health Sciences
Academic / other
Locations1 site (Winston-Salem, North Carolina)
StatusRecruiting
StartedJune 4, 2026
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedJune 29, 2026
Trial IDNCT07143838 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with moderate depression who report cognitive complaints and can complete overnight sleep testing.

Probably not a fit

Individuals who do not show an increase in deep sleep or who have adverse reactions to stimulation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates whether transcranial electrical stimulation delivered during slow-wave sleep can boost deep sleep in adults with depression. EEG-based real-time sleep staging guides stimulation, applied as 0.5-1 mA for five 5-minute blocks with brief breaks. Participants wear an actigraphy device and complete cognitive and mood questionnaires to assess potential sleep, cognitive, and mood benefits. The study uses the Sleep WISP device to deliver stimulation and record data during overnight sessions at Wake Forest University Health Sciences. Outcomes will inform whether enhanced deep sleep translates to improved cognitive performance and mood symptoms in this population.

Why it matters

Potential benefit: If successful, participants may experience better deep sleep, which could be linked to improvements in mood and cognitive function.

How similar studies have gone: Prior work in healthy individuals suggested TES can enhance slow-wave sleep; this study extends testing to people with depression.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to complete overnight sleep study including placement of EEG leads
* Ability to read and understand English.
* Moderate depression
* Self-reported cognitive complaints

Exclusion Criteria:

* Previous adverse reaction to transcranial electrical stimulation
* Presence of implanted devices (e.g. intracranial device, cochlear implant)
* Presence of metal in head (e.g. surgical clip)
* Sensitivity or allergy to silver
* Presence of significant neurologic disease (e.g. Parkinson's disease, epilepsy/seizure disorder, severe migraine disorder)
* History of significant head trauma
* History of stroke or other ischemic event
* Diagnosed with schizophrenia, bipolar disorder, substance use disorder, or presence of current suicidal ideation
* Currently taking medications that could alter EEG or cognitive function
* Presence of severe insomnia
* Presence of severe, untreated sleep apnea
* Currently pregnant
* Planned travel outside time zone during the study

Where it's running

  • Wake Forest University Health Sciences
    Winston-Salem, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.